KK-8123

N/A

Report date: 2024/07/30 20:00:05

Base Information

Drug NameKK-8123
Drug Alias NameKK8123KK-8123
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionAnti-Fibroblast growth factor 23
TargetsFibroblast growth factor 23
Therapy Area/IndicationsFamilial Hypophosphatemic Rickets
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyFrance +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesKyowa Kirin Inc
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Kirin IncKyowa Kirin Co Ltd
Inactive CompaniesN/A
Active IndicationsFamilial Hypophosphatemic Rickets
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A